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Abstract
LONG-TERM EFFECTS OF NOTCH1 SIGNALING ON REGENERATIVE NEURAL STEM
CELLS IN RESPONSE TO TRAUMATIC BRAIN INJURY
By:
Cruz Sevilla Jr.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University
Virginia Commonwealth University, 2019
Advisor: Dong Sun, MD, PhD
Traumatic brain injury (TBI) is a devastating problem which stands as a leading cause of
death and disability. The elderly is significantly affected by TBI, typically as the result of falls,
and recovery is especially limited. This, in part, is associated with decreased tissue-specific stem
cell regeneration and replacement of damaged cells in the aged brain. The diminished ability of
the aged brain to recover is especially devastating after TBI, likely leading to permanent loss of
sensory, motor, and cognitive functions. Studies have shown that the mature mammalian brain
contains Neural Stem Cells (NSCs), found in specific regions of the brain, which can generate
functional neurons during normal and pathological conditions. Two of those regions, the
Dentate Gyrus (DG) of the hippocampus as well as the Subventricular Zone (SVZ) of the lateral
ventricles, have proven to be niches for these multipotent NSCs. A key regulator in the
8

maintenance of these NSCs is the Notch signaling pathway, shown to control proliferation,
differentiation, and apoptosis of NSCs during development and throughout adulthood. In the
current study, we assessed the regulatory mechanisms that drive the regenerative functions of
NSCs in a neuropathological state following TBI. Using the Lateral Fluid Percussion Injury model,
we analyzed the diffuse effects of the injury response on 3-month old male Sprague-Dawley
rats. Immediately following TBI, Notch agonist, antagonist or vehicle was infused into the lateral
ventricle for 7 days to assess the role of Notch signaling on neural stem cell
proliferation/survival and neurogenesis at 30 days post-TBI. Dividing cells during infusion time
were labeled with BrdU via single daily intraperitoneal injections for 7 days. Animals were
sacrificed at 30 days post-injury and brain tissues were processed then immunolabeling for
BrdU and Doublecortin. We found a higher number of BrdU-positive cells in the FPI+Notch1
agonist group when compared to Sham and FPI+Jagged-1 Fc antagonist groups in the
contralateral granular zone. A significant increase in proliferation/survival was also seen in
FPI+Notch1 versus Sham/FPI+Jagged-1 Fc and for FPI+Vehicle versus Sham animals in both the
ipsilateral and contralateral hilus. DCX immunolabeling did not establish a significant difference
in FPI+Notch1 compared to Sham animals, nor across any other groups, which is consistent with
what we know of activation of the Notch pathway. Our results demonstrate that Notch1
signaling is directly involved in cellular proliferation/survival of NSCs in the DG following TBI at
30 days post-injury, but further work must be done to understand the fate of these cells. Thus,
drug treatment targeting Notch1 signaling could serve as a potential therapeutic target
following TBI to preserve NSCs and limit long-term cognitive deficits.
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Chapter 1 – Introduction
Traumatic Brain Injury – Epidemiology
Traumatic brain injury (TBI) is a devastating problem that stands as a leading cause of death
and disability. The World Health Organization recognizes neurotrauma as a critical health
problem often leading to permanent health consequences. Due to the variety of ways it can
occur, neurotrauma stands as a difficult health issue to address. Within the last decade, there
has been a considerable shift in focus on TBI, in part due to advancements in technology
capable of identifying this problem. Vehicle accidents, military combat, accidents at home, and
helmet-to-helmet contact as seen in the NFL have helped draw warranted attention to assess
ways to prevent and respond to neurotrauma.1,2 In addition, research is actively highlighting
differences in the types of TBI, either acute or chronic in nature, to better understand how to
deal with specific instances of injury.2 Specifically, analysis of different biomarkers often seen in
the normal inflammatory process has helped to aid in diagnosis and prognosis of TBI.
In addition to the breadth of examples that lead to neurotrauma, there is as wide a
spectrum of ages of victims who are at risk or have been reported to suffer from this type of
injury. 3–5 Children, adults, and the elderly are all susceptible to lasting physical and intellectual
impairments caused by neurotrauma. Pediatric TBI is considered a chronic condition due to
long-term cognitive and psychosocial deficits suffers, as survivors of injury get older. 4 Adults,
and more specifically athletes, have received highlighted attention to the effects of
concussions. One study of former professional athletes demonstrated that the number of
sports-related concussions served as a predictor for a number of common mental disorders,
10

such as anxiety, depression, and sleep disturbances, 6 while others have compared postmortem, concussed brains to those of Alzheimer’s patients. 7 If a patient is fortunate to survive
from TBI, they will likely endure large economic costs as a result of the necessary long-term
care.1 The elderly is not only extremely susceptible to TBI, but can suffer worse consequences.
A study comparing different aged group mortality rates 6 months post-injury demonstrated
that the group of 64-year-olds and older had more than twice the mortality rate of the younger
group, aged 20 to 40-years-old. This was in spite of the younger group having a more severe
mechanism of injury than the older group.3 Other studies have confirmed and furthered the
correlation of increasing age and increasing mortality rates 8,9 in the elderly and greater
functional decline when compared against younger groups. 10 Within the United States, the
number of people age 65 or older was roughly 48 million in 2015, making up 15% of the total
population, according to the World Health Organization. By the year 2060, that population is
expected to more than double to 98.2 million individuals. People are expected to live longer
thanks to advancements in modern medicine; however, implications of an aging body, such as
pre-existing health conditions, make understanding neurotrauma all the more imperative. 11
As studies begin to dissect the varying degrees of neurotrauma, more can be understood
about how it works and how to treat it. Analysis of different pro-/anti-inflammatory agents
across the Central and Peripheral Nervous system 2 demonstrate the range of
neuroinflammatory responses that are triggered by TBI. Study of specific genes, such as brainderived neurotrophic factor (BDNF), 12 highlight the importance of understanding genetic
factors and their products that play a role in TBI-related issues.
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Our lab has spent the last few years analyzing different aspects of neurotrauma. With a
primary focus on TBI, we discovered valuable information about how the brain responds to
injury. 13,14 The work we have done, as well as work completed by others, primarily focus on
animal models to study these injuries. Short-term consequences of TBI have illuminated
mechanisms involved; however, questions about the long-term effects remain.

Biomechanics and Mechanisms of TBI
Traumatic brain injury occurs as the result of an external force acting and altering brain
function. 15 Instances of TBI are plentiful; as are signs required for classification: loss of
consciousness or memory, disorientation, or loss of balance to name a few. Physical injury
fundamentally shifts the normal mechanisms of the brain to varying degrees, depending on the
type and severity of injury. In the realm of TBI, damage incurred leads to both primary and
secondary injuries. Primary injury is the injury sustained during the traumatic event, often as
the result of falls or mechanical insults. Damage resulting from primary injury includes neuronal
cell death, subdural and epidural hematomas, and vascular damage. 16 Secondary injury
damage can accrue from hours to days after the initial injury and is characterized by metabolic
and cellular changes in the brain. 15
Intracranial damage has been classified in two separate categories: diffuse and focal. As
the name implies, diffuse injury to the brain is frequently widespread. Diffuse axonal injury
(DAI), is a common example of brain injury that results in damage to white matter in the brain.
Focal injuries, in general, involve a pin-pointed focus on certain regions of the brain. These
12

injury types have been broken down to further clarify and understand the post-traumatic
processes following TBI. For example, a proteomic study differentiating the two types of injury
in human brain tissue showed increase expression of peptides related to neurodegeneration
and decreased expression related to antioxidant defense in diffuse TBI patients versus those
suffering focal injuries. 17 This point exemplifies the complexity associated with TBI and why a
thorough understanding of the mechanics is so important.
Differences in injury types for TBI have been demonstrated experimentally in rodents to
better understand ways TBI can be treated.18,19 For example, many studies, including those
done by our lab, utilize fluid percussion injury (FPI) models to replicate clinical TBI without
fracturing the skull.13,20 Lateral FPI model results in damage directly at the point of fluid impact
and diffuse injuries in brain regions far from the impact, whereas midline FPI induces more
diffuse injury As its severity increases, this type of FPI can lead to changes in behavior. 21 Other
models, such as controlled cortical impact (CCI) 22 and acceleration-impact injury models
causing a focal injury are widely used models as well. 23 The overlap between rodent and
human injury mechanisms makes it useful for the potential development of therapeutic
methods for TBI. It is our hope that deeper understanding of these processes will lead to better
long-term care for individuals with TBI.

TBI: Long-Term Consequences
According to the CDC, over 2 million people are thought to be affected each year by
TBI.24 When the brain is physically damaged, the results are not only long-lasting and complex,
13

but costly as well. Estimates of lifetime costs for those suffering TBI span in the millions of
dollars for victims. 1 Besides the immediate damage that results, patients are also subjected to
secondary neurological issues such as personality disorders 25, and chronic pain and
headaches.24 Some studies have demonstrated a connection to patients developing psychosis
and schizophrenia 26, while others have even linked the offspring of parents who have suffered
a TBI to more frequently utilize psychiatric care facilities. 27 Another commonly associated issue
following TBI is major depression in patients. 28

Adult Neurogenesis
The idea of “adult neurogenesis” was previously thought to be somewhat of an
oxymoron until the mid-1960’s, when a duo of scientists uncovered a proliferative region of the
rat brain: the hippocampus; although, Joseph Altman is recognized as the first to discover the
neurogenic potential of cells within the hippocampus.29 He posited that postnatally, there exists
an “undifferentiated” pool of cells that gradually declines in number, resulting in a
corresponding increase in differentiated granule cells. This idea sparked so much of what we
understand about neurogenesis today. Mammalian studies centering around neurogenesis
have solidified the idea first posited by half-a-century ago that a pool of multipotent stem cells
exists after development, lasting through adult life.30,31 In humans, studies done in postmortem
tissue determined the existence of stem cells within the same regions identified in rodent
studies.32 Of course, humans and rat development and maturation processes are not exactly
equal, but have been reviewed and compared showing enough similarity to demonstrate the
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value in understanding the mechanisms of the latter to gain insight on the former. 33 Due to
restrictions and ethical issues in studying developing human tissue, rat and mouse models are
used to investigate the mechanisms that make up this process. Scientists are actively comparing
developmental neurogenesis and that seen throughout adult life. 34
Neural Stem Cells (NSCs) are a recently uncovered tool of significant importance in brain
development, maturation, and recovery. Residing within specific regions of the brain, the NSCs
are a class of self-renewing cells with the capacity to generate new neurons and other cell types
within the nervous system. These regions, often referred to as the neurogenic niches of the
brain, are capable of sustaining proliferation and differentiation from the preexisting pool of
stem cells. Today, it is well understood that those two regions include the dentate gyrus (DG)
of the hippocampus and the subventricular zone (SVZ) of the lateral ventricles. 13,29,30,35–37 Stem
cells from each specific region have their own capacity to differentiate. For example, in vivo
progenitor cells that come from the SVZ of the lateral ventricles have a specific path of
migration towards the olfactory bulb. These cells travel along what is known as the rostral
migratory stream (RMS) and will potentially become mature olfactory neurons. 30 Studies have
shown cells of the SVZ will also become olfactory interneurons vital for olfactory discrimination,
sensitivity, memory and specificity.38 In all, these cells relay sensory information to the olfactory
cortex and serve a vital role in odor processing.38,39 Structurally, rodents have a relatively larger
volume of the olfactory bulb in comparison to humans, which has made analysis of the SVZ
both common and useful.
In both rodents and humans, the stem cells residing within DG of the hippocampus play
a different role than those in the SVZ. Studies have demonstrated the NSCs of the DG to have a
15

significant role in learning, memory, and cognitive function. 36,40 Cells residing within the DG can
become excitatory granule cells whose axons form the mossy fiber tract. 40 This tract connects
the DG to the CA3 region of the hippocampus. The dentate gyrus (Figure 1.1) has been broken
down further into subregions, including the molecular layer (MOL), the granular cell layer (GCL),
and the hilus or polymorphic layer. The granular layer, often referred to as the granular zone,
consists of a subregion called the subgranular zone (SGZ) which is now known to be the site of
origin of stem cells. Cells within the SGZ can travel through the granular cell layer toward the
molecular layer as they differentiate. 41 While the final location differs for stem cells within the
different neurogenic niches, both processes have been determined to be controlled in part by
molecules in the extracellular matrix and ligands found on other cells. 42
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(A)

(B)

Figure 1.1 The Dentate Gyrus of the Hippocampus. Image extracted from Scharfman 2016. (A)
Depicts a breakdown of the layers of the dentate gyrus DG of the hippocampus. The molecular
layer, the granular layer, and the hilus are all pictured. (B) Demonstrates a coronal section of
the same DG structures.
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Stem cells progress through different phases (Figure 1.2) as they mature. In general,
NSCs will differentiate to neural progenitor cells (NPCs) before becoming mature neurons. A
thorough background of adult hippocampal neurogenesis has been established, exposing
distinct phases and corresponding cell types.35 These phases are triggered by specific signals
and as the cells progress through the stages and can be classified by differences in morphology.
The first stage of neurogenesis consists of Neural Stem Cells (NSCs), which differentiate into
Type 1 Neural Progenitor Cells (NPCs). The latter cell type then differentiates into a Type 2 NPC
before differentiating further into a Neuroblast. 34
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Figure 1.2 Differentiation of NSC’s in the DG. Image extracted from Kempermann et al.,
2015. This visual represents the progression of neurogenesis through various phases, from NPC
to a mature neuron. Additionally, stage-specific markers are noted on the right.
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While studies have demonstrated differences within the makeup of young/mature NSCs,
the overarching view of adult neurogenesis has been one of a continuation of development. 34
This has made the understanding and investigation of the developmental process key to
providing insight on how the adult brain functions. Neural stem cells are also known to be an
active component of regenerative processes, as well as homeostatic conditions. Character traits
of stem cells have allowed for manipulation of growth to better understand the proliferation
process. One study identified a certain type of stem cell within the SVZ to contain epidermal
growth factor receptor (EGFR). When presented with EGF, this receptor signals for proliferation
of the NSC. 43 Knowledge of the intrinsic properties of stem cells has allowed for comparisons in
other drug treatment studies, such as these experiments. Although there is an overlap in the
developmental process and adult neurogenesis, there exists a difference in the responsiveness
of tissue that is aged dependent. Dr. Sun et. al, completed work that demonstrated specifically
how aged tissue is worse at recovering from TBI than its younger counterpart. Specifically, we
demonstrated that aged tissue has a higher apoptotic response and reduced levels of
proliferation within the DG of the hippocampus. 14,44 There exists an age-related decline of a
tissue’s capacity, which is due to NSC’s gradual decline in potency. Further, there is an agerelated impairment of hippocampal cognition found in both humans and primates. 33
Interestingly, the result of reduced neurogenesis in aging tissue does not occur from loss of
NSCs, but rather a transition of the stem cells from a potent-to-quiescent state. 45 This was
demonstrated via a correlation between a loss of active horizontal NSCs in aged mice, rather
than a decrease in quantity of the observed NSCs. Establishing an understanding of how aging
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tissue behaves can further aid in the process of treating both the elderly population, as well as
those who suffer neurotrauma.
Notch Signaling Pathway
Current research has begun to unveil the mechanisms in which NSCs function. The Notch
Pathway has been implicated as a key regulator in neurogenesis. 46–48 Our lab and others have
begun mapping the downstream effects of Notch activation and demonstrating its role on for
NSCs. Notch is thought to be critical for NSC maintenance and differentiation as well as learning
and memory.49 Serving as a regulator for the timing of motor neuron genesis as well as
maintaining the progenitors in a proliferative state under homeostatic conditions 50, the role
and importance of Notch is likely to carry over into recovery following neurotrauma.
The pathway is a simple, well preserved process which is associated with other well studied
regulatory mechanisms in tissues that undergo neurogenesis, hematopoiesis, and more. 51,52
Through interactions with exposed ligands, such as Jagged 1/2 and Delta-like ligands 1/3/4,
from neighboring cells, the Notch receptor itself is cleaved via gamma-secretase, resulting in
the release of the Notch intracellular domain (NICD) Figure 1.3. This portion will then
translocate into the nucleus and interacts with a class of proteins in humans known as CSL
(CBF1, Suppressor of Hairless, and Lag-1). These proteins act as transcriptional activators,
producing a series of products dependent on the type of Notch receptor activated. Although
there are several different Notch receptors which have been discovered, it appears that Notch
2/3 have similar, repetitive functions.53 Commonly seen products are Hes1/Hes5, or hairy and
enhancer of split family.52 Hes genes have been demonstrated to be important for
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transcriptional repression in one study of a loss-of-function hematopoietic stem cell line. 52 In
the nervous system, experiments have shown that Hes is vital for maintaining the pool of neural
stem cells by inhibiting neuronal transcriptional effectors (Neurogenin/Mash1). 48 A knockout
study done in mice demonstrated that upregulation of Hes1 resulted in differentiation of NPCs,
while its downregulation caused the opposite effect. 54 In a simplified sense, Notch signaling
products act on the existing pools of NSCs to prevent differentiation and thereby maintaining
them in their proliferative state. Current studies have helped understand the role of Notch on
NSCs during development and adult maturation. What remains unclear, however, is the extent
that Notch plays in recovery following TBI.
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Figure 1.3 The Notch Signaling Pathway. Image extracted from Yoon et al., 2005.55 Notch
receptor activation requires an extracellular protein from another cell to trigger the signaling
cascade. ɣ-secretase cleaves a portion of the Notch receptor, the NICD, which translocates into
the nucleus, resulting in transcription of genes like Hes.
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TBI-induced neurogenesis (TBI and the Notch pathway)
Animal models are currently the most popular options to replicate TBI because of
standardized outcome measurements, low costs, and other factors, although some studies
have utilized larger animals.18 In Dong Sun’s lab, work has been completed to establish the
neurogenic niches in the adult brain and to demonstrate that Notch signaling is a key regulatory
mechanism which mediates regenerative NSC response post-TBI.56 Increased levels of Notchspecific proteins were also observed within the SVZ of a 3-month TBI rat. It was noticed that in
comparing the levels of those same proteins in aged versus young rats, the levels were
markedly lower in the former.14 Generally, the older the tissue becomes, the worse it becomes
at recovery. Within the nervous system, when compared to younger tissue, aged tissue is
associated with decreased tissue-specific stem cell regeneration and replacement of damaged
cells56. Thus, this aging-related character of tissue compounded with TBI frequently results in
permanent loss of sensory, motor, and cognitive functions as the result of brain injury.
Presently, there is little-to-no knowledge available about the role of Notch following TBI;
however, we speculate that Notch could likely play a role in regulating TBI-induced NSC
regulation based on its role in development.

Hypothesis
Our focus in this study was to analyze the longer-term effect of Notch signaling on
neurogenesis following traumatic brain injury. By manipulating the Notch signaling pathway
through administering Notch agonist (Notch1 antibody) or Notch antagonist (Jagged1 Fusion
24

protein), we set out to assess how NSCs from the neurogenic niches would respond following a
moderate TBI. With our previous work as a foundation, we expanded upon a 7-day study that
involved administration of the same drug treatment groups to determine the difference at 30
DPI. We hypothesized that increased activity of the Notch signaling pathway through the
Notch1 antibody would result in increased proliferation/survival and decreased differentiation
of NSCs within the DG. Contrarily, we expected inhibition of the same pathway to result in
decreased proliferation and increased differentiation of stem cells in the hippocampus.
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Chapter 2 – Materials and Methods
Experimental animals
The focus of this experiment is to determine the effects of Notch Signaling on long-term
endogenous neural stem cell proliferation, survival and differentiation in the dentate gyrus of
the hippocampus following traumatic brain injury. Adult rats were exposed to a moderate
traumatic brain injury, followed by an intraventricular administration of a Notch agonist
(Notch1), Notch antagonist (Jagged-1 Fc), or Vehicle infusion for 7-days via osmotic minipump.
A total of n=21, male, 3-month old Sprague-Dawley rats (ENVIGO Corporation) were utilized.
Weighing roughly 300 grams, the rats were provided food and water ad libitum while housed in
pairs in a Plexiglas cage on a 12-hour light cycle. Procedures and handling followed the ethical
care guidelines and were approved by the Institution of Animal Care and Use Committee
(IACUC) of Virginia Commonwealth University, the Guide for Care and Use of Laboratory
Animals and by the U.S. Department of Health and Human Services.

Experiment Setup
Animals were randomly separated into four groups. Three of those four groups were
exposed to traumatic brain injury (TBI) and were further separated based on drug treatment.
All animals received the same care and housing. Group one, the Sham group, was composed of
five animals, did not receive TBI, but was exposed to the same surgical procedures as the other
groups. Sham group did not receive any drug treatment. Group two, the Vehicle group, had five
animals, underwent surgery, and received artificial CSF (aCSF) infusion for 7 days-post-injury.
26

Group three, the Notch antagonist group, had five animals, underwent surgery, and was infused
with Jagged-1 Fc for 7 DPI. Group four, the Notch agonist group, had six animals, underwent
surgery, and received the Notch agonist infusion for 7 DPI. Each group of animals was given
single, daily intraperitoneal injections of 50 mg/kg BrdU for 7 DPI. All animals were sacrificed at
30 days-post-injury (DPI).

Table 2.1 Animal Grouping
N=

Injury

Drug Treatment

Dosage

Group 1 - Sham

5

No

No

N/A

Group 2 – FPI + Vehicle

5

LFPI

Yes, aCSF (Vehicle)

100ul

Group 3 – FPI+ Jagged-1

5

LFPI

Yes, human recombinant

50µg/mL

(Notch antagonist)
Group 4 – FPI + Notch1

Jagged-1 fusion protein
6

LFPI

Yes, Notch1 antibody

2µg/mL

(Notch agonist)

Table 2.1 Animal Grouping. Animals were split into 4 groups. Group 1 was the only group not
exposed to a Lateral Fluid Percussion Injury (LFPI) or drug treatment. Group 2, 3, and 4 all were
subjected to Lateral Fluid Percussion Injury and received Vehicle (aCSF), Notch1 antagonist
(Jagged-1 Fc) and Notch1 agonist (Notch1 antibody) infusions for 7 days, respectively. All
groups were given intraperitoneal injections of BrdU at 50mg/kg of body weight for 7 days
post-injury.
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Surgical procedures
Animal groups were dividedly at random to undergo LFPI or Sham injury. Sterilization of
all surgical instruments was complete prior to surgery. During surgery, aseptic procedures were
followed through completion to minimize risk. All adult rats were individually contained within
a Plexiglas holding chamber and anesthetized by exposure to 5% isoflurane until unconscious
and breathing rate significantly slowed. The animal’s head was then shaved to expose an area
for incision. Next, it was placed within a stereotaxic apparatus which stabilized the position of
the animal for surgery. Continuous treatment of isoflurane (2.5%) in a 70% Nitrogen and 30%
Oxygen gas mixture was given through a nose piece to keep the animal anesthetized. To
sterilize the surgical site along the animal’s head and to prevent the animal’s eyes from drying,
Betadine and Paralube ointments were applied, respectively. From here, the animal was incised
along the midline of the skull using a scapula and the skin was retracted on both sides using a
hemostat. Excess connective tissue was removed using sterilized cotton swabs. This exposed
the area of the skull for a 5 mm craniotomy to take place. With the lambdoid and sagittal
sutures as landmarks, the craniotomy was carried out approximately 1.5 mm anterior to
lambdoid suture and 2 mm lateral to the midline suture on the left parietal bone using a
trephine and a Dremel drill. An outline created by the trephine allowed for a clean circular area
of skull to be removed. If necessary, small shards of bone were carefully removed to create a
clear exposure to the brain. This area was utilized for placement of the hub cap, which
connected to the Fluid Percussion injury instrument. In addition, a burr hole was created
approximately 1.5 mm laterally and 1 mm posteriorly from bregma and was the point for
implantation of the intraventricular infusion cannula. After implantation of the infusion cannula
28

into the injury ipsilateral side lateral ventricle, the cannula was secured with dental acrylics. The
cannula connected osmotic min-pump was then embedded subcutaneous at the back of the
neck. Once surgery was complete, the animal was sutured with a 4-0 monofilament in a running
locking pattern. Application of lidocaine jelly and a triple antibiotic ointment were generously
applied to the closed wound and isoflurane treatment ceased. From here, the animal was
monitored to ensure normal breathing began and continued. Animals were returned to their
recovery cage and placed over a warming pad. They were observed for 15 to 20 minutes postoperatively to ensure normal functions returned. The pump was removed at 7 DPI.

Lateral Fluid Percussion Injury
Moderate Lateral Fluid Percussion Injury (LFPI) was utilized for this project. Once the
region of the parietal bone was carefully removed, a hub connector was cemented to the skull
using cyanoacrylic, then dental acrylic was mixed and applied around the base of the hub and
allowed to harden. To ensure proper alignment, it was noted that no acrylic leaked within the
space of the hub and the area was rinsed with 0.9% saline solution with the expectation that
the solution would not diffuse through the area of exposed brain tissue. Once the safety checks
were considered, isoflurane was gradually decreased to 1.5% while prepping and testing the
Fluid Percussion instrument. To establish a precise administration of a moderate injury within
the range of 2.05 ± 0.05 ATM, the height of the pendulum was adjusted such that upon release
and impact, the associated calibration devices displayed an output of the desired pressure.
Those devices were a pressure transducer amplifier and a Tektronix oscilloscope. Figure 2.1 (A)
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and (B) display the FPI instrument and calibration devices, respectively. After appropriate
pressure readings were measured, the animal was removed off isoflurane until tail reflex was
back, then connected via the hub to the Fluid Percussion injury instrument. The pendulum was
released, inducing injury, and the exerted pressure was recorded. Upon injury, a timer was
started to record the subsequent responses. Once the animal was removed from the device, it
was immediately placed in a supine position on the table and assessed for breathing. If a
respiratory response was not present, manual stimulation was given. Once breathing returned,
animals were monitored for paw, tail, and righting reflex in that order. An external physical
stimulus was applied to the animal’s hindlimb and tail until flexion occurred in both. Righting
time was determined as the time it took the animal to bring itself upright from its side. These
reflexes have been established to determine completeness of injury. 57 After, the animal was
brought back to the surgical area and placed back under anesthesia with 5% isoflurane to
remove the hub and dental acrylic. In addition, a burr hole was created for insertion of the
infusion cannula for intraventricular drug infusion. Observing the intersection between the
coronal and midline sutures allowed for identification of bregma. From the established 0 point,
the stereotaxic arm was moved 1.5 mm laterally and 1 mm posteriorly to locate the ipsilateral
ventricle. The depth of the implanted infusion cannula was 3mm from the dura surface. Dental
acrylic was applied around the base of the cannula to secure it. The connected osmotic mini
pump was embedded subcutaneously. Finally, the surgical site was closed.
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(A)

(B)

Figure 2.1 The LFPI instrument and oscilloscope. (A) Shows the Lateral Fluid Percussion
Instrument used to deliver injury through a fluid-pulse. (B) Demonstrates a recorded pulse from
the oscilloscope, which displays a frequency (Hz) based on the current of the fluid flowing
through the tube. Conversion of Hz to pressure (atm) was calculated after.
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Drug Dosage Determination
The three LFPI groups were separated to receive Vehicle, Notch1 antagonist, or Notch1
agonist infusions. The 7-day infusion mini-pump contains 100ul of infusion solution. The vehicle
group was infused with 100ul of aCSF. As previously described by Sun et al. 2010, the
composition of aCSF consisted of 148mM NaCl, 3mM KCl, 1.4mM CaCl2, 0.8mM MgCl2,
1.5mMNa2HPO4, and 0.2mMNaH2PO4 at a pH 7.4. The Jagged-1 Fc and Notch-1 groups were
selected to receive a pre-determined concentration of the selected drug, at 50µg/mL and
2µg/mL, respectively. These doses were selected based on the dose response study examining
DG neural stem cell proliferative response following Notch1 agonist and antagonist infusion
determined previously in our lab.

BrdU Injections
To label dividing cells, animals were intraperitoneally injected with bromodeoxyuridine
(BrdU) at 50 mg/kg body weight, single, daily for 7 days during the infusion period. BrdU is a
thymine analog, which incorporates into the DNA of all proliferating cells during S-phase. Thus,
BrdU serves as a crucial indicator of quantity and timing of newly formed DNA/replicating cells
within the specific timepoint of injury, as seen in previous studies. 20
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Sacrificing and Tissue Preparation
At 30 DPI, all animals were sacrificed by transcardic perfusion. Animals were placed in a
Plexiglass container and deeply anesthetized with an overdose of isoflurane inhalation. A gauze
pad soaked in isoflurane was used to cover the animal’s facial area to maintain that the animal
stayed unconscious. An incision was made along the midline of the thoracic cavity, exposing the
heart. The heart was cross-clamped using rubber tipped hemostats, then a blunt-tip, 16-gauge
needle was inserted through the left ventricle into the aorta. Next, the right atrial appendage
was cut to allow the exit of blood. A transcardial perfusion was completed, using 150 mL of
Phosphate-buffered Saline (PBS) and 150 mL of 4% Paraformaldehyde in PBS fixative. PBS
flowed through the needle, circulating throughout the animal’s vascular system. The flow of
PBS was continued until the fluid exiting the right atrium was clear and the liver, as well as
other organs, had lost their dark color. From here, Paraformaldehyde flowed through the
animal’s circulatory system to serve as a fixative for the tissues. After fixing the tissue, the
animal was decapitated, and the brain was carefully extracted out from beneath the skull.
Brains were kept in 4% paraformaldehyde at 4°C until they were sliced. Using a Vibratome
(Figure 2.2), the brains were sliced coronally into 60 µm slices throughout the ventricles and
hippocampus. Sequential sections were collected in 4 sets into 24-well plates that were filled
with PBS and 0.01% sodium azide, then stored in the 4ºC for preservation until further
processing. Brain sections were used accordingly for immunostaining.
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(A)

(B)

(C)

Figure 2.2 Tissue slicing and processing. (A) This image captures the Vibratome, used for slicing
tissue samples. (B) Rat brains were sliced coronally into 60 µm slices throughout the ventricles
and hippocampus and collected in 24-well plates filled with PBS and 0.01% sodium azide. (C)
Tissue samples were immunostained and mounted on Superfrost slides, counterstained with
Crystal Violet, then covered using Permount solution and coverslips.
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Immunohistochemistry
Two separate immunostaining techniques were utilized for this experiment. For each
brain, 12 sequential sections spanning 480 µm throughout the lateral ventricle and
hippocampus were selected and were processed for immunostaining of a specific marker. This
ensured that equal and complete coverage of the hippocampus and ventricles were accounted
for each animal. Our goal was to identify the presence of BrdU and doublecortin (DCX), an
immature neuronal marker. The protocol for staining was similar for both markers except the
DNA denaturing steps for BrdU. Briefly, sections were rinsed in 1X PBS two times for five
minutes each. For BrdU staining, a denaturing solution composed of 50% formamide, 37.5%
Nanopure H2O, and 12.5% 20X Sodium Saline Citrate Buffer (SSC) was used. The sections were
denatured for one hour in an oven set at 65°C. Next, sections were removed from the oven and
rinsed with 2X SSC for five minutes, two times. After, sections were further denatured in 2N
Hydrochloric acid (HCl) for 30 minutes in a 37°C oven. Sections were then rinsed again in 1X PBS
for five minutes, twice. From the previous step onward, the protocols for BrdU and DCX were
identical. Following the wash, the trays were quenched in 3% hydrogen peroxide for 1 hour. A
mixture of 1X PBS with 0.3% Triton X-100 was placed in the trays for 10 minutes. Sections were
incubated with a blocking buffer, consisting of 5% horse serum in 1X PBS + 0.3% Triton,
overnight at 4°C. The following day, the blocking buffer was removed, and the specific primary
antibody solution was prepared: for BrdU, primary monoclonal mouse antibody solution (Life
Technologies Corp) was set at a dilution of 1:2000 in blocking buffer. For DCX, primary goat antiDCX (Santa Cruz Biotech) was made at 1:1000 dilution in blocking buffer. Sections were
incubated with the primary antibody solution for 48 hours at 4°C on shaker. Sections were then
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brought back to room temperature and rinsed with 1X PBS + 0.3% Triton for 10 minutes, three
times. After, they were placed in blocking buffer for 3 hours at room temperature before being
placed in secondary antibody solutions overnight at 4°C. The secondary antibody solution for
BrdU was prepared as follows: A Biotin-conjugated anti-mouse antibody, measured at 1:200
dilution in blocking buffer, from horse (Vector Laboratories, Inc) was prepared. The DCX
secondary antibody (Vector Laboratories, Inc) solution was anti-goat, biotinylated IgG, prepared
at 1:200 dilution in blocking buffer. Sections were incubated with the secondary antibody for
overnight at 4°C on shaker. On the last day, the sections were brought back to room
temperature and washed in 1X PBS for 10 minutes, three times. Because our secondary
antibodies were Biotin-conjugated antibodies, the sections were further incubated with an
Avidin-Biotin Complex (ABC) solution for two hours at room temperature. This solution works
by associating with Biotin-conjugated secondary antibody, increasing staining intensity of the
tissue. The ABC solution was prepared at 1:200 dilution in 1x PBS 30 minutes prior to use.
Following 2 hours of exposure, the sections were washed with 1X PBS three times for 10
minutes. Concurrently, DAB solution, consisting of dry diaminobenzidine tetra-hydrochloride
(DAB) (Sigma) was prepared. With the help of a peroxidase, DAB can be oxidized in the
presence of hydrogen peroxide, forming a brown precipitate that is easily visualized under the
microscope. For every 10mg of DAB, 40 mL of Phosphate Buffer and 17.5 µL of 30% hydrogen
peroxide was added. Tissue sections sat in DAB solution for 5-15 minutes and allowed to react
under the microscope. (Figure 2.3) After the precipitate was visualized, the sections were
washed a final time in 1X PBS for 5 minutes, three times, and carefully mounted on Superfrost
slides to be stored until further processing.
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(A)

(B)

Figure 2.3 Positive DAB staining for BrdU. (A) and (B) Positive DAB staining for BrdU was
observed under a microscope within the dentate gyrus (DG) of the hippocampus and the
subventricular zone (SVZ) of the lateral ventricles, respectively. The reaction was visualized by a
darkening of these regions of interest. (A) shows an example slice of the hippocampus while (B)
shows staining in the SVZ. Scale bar = 2mm.
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Crystal Violet Counter Staining
The Crystal Violet stain (Biochemical Sciences, Inc) was used to help to identify the
morphology of brain sections. Crystal violet binds to Nissl substance, which is found in the soma
and dendrites of neurons and glial cells. Nissl is composed from the cell’s rough endoplasmic
reticulum thus can be closely associated with the soma. Axons, on the other band, have little
Nissl present so therefore appear lighter in color after exposure. Crystal violet assays have been
demonstrated to help quantify samples based on staining intensity. 58 During cell death, a
typically adherent cell will dissociate from culture and is lost from that sample, thus decreasing
the amount of crystal violet staining. The overall staining of the tissue created a purple
backdrop to quantify cells within the regions of interest. After hydrating in distilled water for 3
minutes, a tray of slides was placed in a 1:100 dilution of Crystal Violet in distilled H 2O for 35
seconds, then immediately placed back in pure diH2O. Next, the tray was placed in two
separate containers of 75% ethanol for 2 minutes, then placed in 95% ethanol for 3 minutes.
Following, the tray was moved into two 100% alcohol containers for 3 minutes each. Ethanol
steps were intended to slowly dehydrate the tissue sections. Then, they were placed in one
container of Xylene (Citrisolv, Deacon Lab) for 3 minutes, and another container of Xylene for 5
minutes. Xylene serves the role of a defatting agent. All containers housed a volume of solution
of 250mL. Finally, coverslips were placed over the slides and sealed using Permount solution.
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Stereology
After crystal violet staining was complete, all slides containing regions of the
hippocampus were analyzed. Five sections, spanning 480 µm, throughout the hippocampus
were selected for each brain. Sections were observed under an inverted light microscope,
Olympus DP71, which was paired with the Visiopharm Integrator System (Olympus) program.
These tools allowed for cell quantification and tissue thickness calculation of the Dentate Gyrus
(DG). The DG was broken down into the following areas: The Molecular Layer (MOL), the
Granular Cell Layer (GCL) and the Hilus. Between the GCL and Hilus exists a layer called the
Subgranular Zone (SGZ), which is a roughly two-cell thick layer, staining prominently with
crystal violet. Cell bodies are easily identifiable within the region of the SGZ, and extensions of
the cells typically extend through the GCL to the MOL, as seen experimentally by our lab and
others 44,59 To start, sections were focused under a 4x objective lens and the outlines were
made around the DG and Hilus excluding the region of the hippocampus identified as CA3.
Every positive BrdU cell was counted across the entire height of the optical dissector, using the
optical fractionator method. The dissector height (h) was set to 15 µm and sections were
analyzed across that range. Cells outside the height were not included in the total. The total
number of cells were counted on both the ipsilateral and contralateral side of the tissue of both
the Granular Zone and Hilus. The values reported for BrdU cells represents the sum of all cells
for each animal, and the total number of stained cells was calculated to give the estimated
number of cells throughout the DG of the hippocampus. Using the Optical Fractionator (3D)
equation n= ΣQ · (t/h)(1/asf)(1/ssf), where the sum Q equals the total number of particles, (t/h)
is defined as the average section thickness divided by counting frame height, asf represents the
39

area sampling fraction and was equal to 1, and ssf was valued at 1/8 and represented the
section sampling fraction. The latter value was determined by calculating the total number of
sections collected for each brain and assessing that every eighth tissue sample was used in this
methodology. To determine thickness of the tissue, 5 separate measurements of the focal
plane of each section were taken. These numbers were averaged to determine the average
tissue thickness value for each animal.
Statistical Analysis
To determine significance, a one-way ANOVA test was run with the SPSS software. A
multi-group comparison was complete across the four groups introduced. Included in the
analysis was a look at the difference in cellular proliferation of the GZ and Hilus, on both the
ipsilateral and contralateral sides of injury. A Bonferroni test was used with a significant p value
of less than 0.05.
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Chapter 3- Results
In this study, we focused on the longer-term effects of the Notch signaling in regulating
survival of proliferating neural stem cells and generation of new neurons in the DG of the
hippocampus following TBI. In this experiment, we quantified the number of cells representing
stem cell proliferation/survival (BrdU-positive cells) and neural differentiation (DCX-positive
cells) at 30 days post-injury across Sham, FPI+Vehicle, FPI+Jagged-1 Fc (Notch1 antagonist), and
FPI+Notch1 antibody (Notch1 agonist) groups. . All four groups were analyzed to determine the
difference in proliferation/survival and differentiation within the same region of the brain: the
dentate gyrus of the hippocampus. For cell counting, the DG (Figure 3.2) was further divided
into the granular zone (GZ) and the hilus region. An example of a BrdU+ cell, located within the
subgranular zone of this section, was identified by its circular nucleus and dark color. Figure 3.3
compares all four animal groups and demonstrates the noticeable difference in proliferation in
the hippocampus. To analyze our results, we ran a one-way ANOVA multi-group comparison.
We specifically ran a Bonferroni Post Hoc, comparing mean differences with a 95% confidence
interval to identify significant differences between groups. Our threshold for significance was
set to p<0.05.

Determining the longer-term role of Notch1 signaling in survival of proliferated cells following
TBI.
To study the effects of activation of Notch signaling on NSCs within the neurogenic
region of the hippocampus, we used a Notch1 antibody (anti-Notch Extracellular clone 8G10)
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which acted as an agonist on the Notch1 receptor. Conversely, to assess the effect of Notch
signaling inhibition on post-TBI neurogenesis, we used human recombinant Jagged-1 Fc, a
receptor blocking fusion protein. This fusion protein works to inhibit Notch signaling by binding
to a ligand of the Notch1 receptor, Jagged1.56 Previous studies have shown that activating
Notch results in proliferation of stem cells not only in the CNS, but stem cells of non-neural
origin as well.60,61 More recent work has focused on Notch manipulation by blocking the Notch
pathway using siRNA against Notch or a ɣ-secretase inhibitor, leading to significantly reduced
downstream transcriptional effectors. 62 These data, along with our preliminary work, solidified
our use of these drug treatments. In the current study, animals were infused with 2µg/mL of
Notch1 or 50 µg/mL of Jagged-1 Fc intraventricularly through an osmotic pump immediately
following injury for 7 days. As previously demonstrated by our lab, we analyzed completeness
of injury across the vehicle and drug infusion groups by comparing the righting response time of
animals post-injury. 20 Righting time (Figure 3.1), among other neurobehavioral measures, were
measured following lateral FPI to establish a baseline level of injury amongst animal groups. 63
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Figure 3.1 Animal Righting Time Following Injury. The righting time of each animal was
recorded following LFPI. No significant differences were seen across groups. Error bars = 2x SE.

Analysis of Cellular Proliferation/Survival at 30 DPI
Intraperitoneal BrdU injections (50mg/kg) were given once daily following injury for 7
days to timestamp proliferating cells for all groups. Due to its similar structure to the DNA base
thymine, BrdU is a trusted immunohistochemical tool for labeling proliferating cells. The
thymine analog incorporates into DNA of dividing cells during S-phase of the cell cycle. 64 As
BrdU was only available for 2 hours after injection to incorporate into DNA of proliferating cells
during the 7 days injection period, and since animals were sacrificed at 30 days, the number of
BrdU-labeled cells in this study represents proliferating cells during the injection period that
survived at 30 days post-injury. As shown in Fig. 3.3, BrdU staining was mostly observed in the
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granular cells layer of the DG. Intensity of staining represents different stages of division.
Darker staining represented a more stable state in which BrdU was not diluted due to division,
whereas lighter staining represented that the cell went through multiple divisions, thus BrdU
was more diluted. BrdU+ cells were also observed not only in the subgranular zone where the
DG neurogenesis occurs, but also into the middle and outer layers of the GZ indicating that
BrdU-labeled dividing cells migration from the SGZ to the GZ.
In counting the total number of BrdU+ cells using unbiased stereology method, we
found that the number of BrdU+ cells was significantly higher in both the granular zone and
hilus of the dentate gyrus in animals with Notch1 agonist infusion when compared to Sham
animals. (Figure 3.4) Specifically, the number of BrdU+ cells in the Notch1 agonist group was
significantly higher on the contralateral side of GZ (p=0.015) and was trending towards
significance on the ipsilateral side of injury (p=0.057) when compared to Sham levels. On the
contralateral GZ, the number of BrdU+ cells were also significantly higher in the Notch1 infused
group than the Jagged-1 Fc group (p=0.046). In the hilus, the FPI+Notch1 agonist group had a
significant increase in the number of BrdU+ cells on the ipsilateral side (p=0.001) and
contralateral side of injury (p=0.000024) versus Sham. In addition, BrdU+ cell in the Notch1
group was increased significantly against the Jagged-1 Fc antagonist group on the ipsilateral
(p=0.049) and contralateral (p=0.000216) side of injury within the Hilus. Lastly, comparison of
the Vehicle group versus Sham demonstrated that injury alone resulted in a significant increase
on the ipsilateral Hilus (p=0.019) and was trending towards significance contralaterally
(p=0.055). Collectively, the BrdU data suggested that activation of Notch1 signaling following
TBI enhances survival of proliferated neural stem cells at the chronic stage when compared to
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Sham animals following TBI, whereas Notch1 signaling inhibition decreases survival of
proliferated cells when compared to the Notch agonist group.
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(B)

(A)

Figure 3.2 Visualization of BrdU+ staining along the GZ and hilus. In this image, we
demonstrate what qualified as a positively stained BrdU+ cell. Morphologically, BrdU+ cells
were identified as the round nucleus of the cells and the darkened color in contrast to
background staining. BrdU+ cells were typically found along the Subgranular Zone (SGZ) and GZ
of the DG while fewer were found within the polymorphic layer (hilus). (A) Shows a section at
4x magnitude, while (B) is shown at 40x.
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(D)

Figure 3.3 Visualization of BrdU+ staining across treatment groups. Representative images of
60µm thick coronal hippocampal tissue sections processed for immunostaining against BrdU
and counterstained with Crystal Violet Nissl stain. Sections were observed under a 4x lens to
map the GZ and Hilus of the DG. (A) Sham (B) FPI+Vehicle (C) FPI+Jagged-1 Fc and (D)
FPI+Notch1. Scale bar = 100 µm.
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Figure 3.4 Quantification of BrdU positive cells at 30 Days Post-Injury. Proliferation/survival of
DG neural stem cells was determined by quantifying the number of BrdU+ cells for Sham,
FPI+Vehicle, FPI+Jagged-1 Fc, and FPI+Notch1 groups at 30 days after TBI. Counts were
measured on both the ipsilateral and contralateral side of injury in the hilus and granular zone
(GZ) of the hippocampus using stereological principles. (A) In the GZ, the levels of BrdU+ cells
in the FPI+Notch1 agonist group was significantly higher in the contralateral side (p=0.015) and
was trending toward significance in the ipsilateral side (p=0.057) when compared to Sham. The
number of BrdU+ cells in the FPI+Notch1 group was also significantly higher compared to the
FPI+Jagged-1 treated group. (B) In the ipsilateral hilus, the number of BrdU+ cells in the
FPI+Notch1 agonist group was significantly higher compared to Sham (p=0.0001) and
FPI+Jagged-1 Fc (p=0.049) groups. FPI+Vehicle group had a significantly higher number of BrdU+
cells when compared to Sham in the ipsilateral (p=0.019) and contralateral (p=0.011) hilus. In
the contralateral hilus, the number of BrdU+ cells in the FPI+Notch1 agonist group was also
significant higher compared to Sham (p=0.000024) and FPI+Jagged-1 Fc (p=0.000216) groups.
Note that: (*p<0.05, ***p<0.0001) and Error bars set to 2x SE.
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Analysis of Neural Differentiation 30 DPI
In addition to examining Notch signaling manipulation on cell proliferation and survival
within the dentate gyrus of the hippocampus, we also assessed changes in Notch1 signaling in
the generation of new neurons at the chronic stage following TBI using DCX as the marker.
Doublecortin X (DCX) was discovered as a microtubule associated protein involved in migration
of neural progenitor cells (NPC’s). 65 DCX is a marker commonly used to identify the presence of
immature granule cells and migrating neuroblasts 66–68. In Figure 3.5 (A-D), example sections for
each group are shown to demonstrate the staining patterns seen in the DG. Typically, darkstaining regions of cell bodies could be identified around the SGZ of the DG. Less frequently
would cells be found in the hilus region. Additionally, cells were categorized by morphology of
their dendrites and identified as vertical, horizontal, or mixed dendrites. This marked their stage
of maturation stage, with vertical dendrites indicating a more mature stage, as shown in Figure
3.5 (E-G).
For quantification, the total number of DCX+ cells regardless of their dendritic
morphology were lumped together. In both the ipsilateral and contralateral GZ, the number of
DCX+ cells were slightly higher in the sham and TBI-Vehicle group compared to TBI-Notch1
agonist and TBI-Notch1 antagonist groups. However, the difference did not reach statistical
significance. There is no difference in the number of DCX+ cells between the Notch1 agonist
and antagonist group as well. In the Hilus, the mean value of DCX+ cells for the FPI+Vehicle
group was higher than the other three groups on both sides of injury but did not reach
statistical significance in the multi-group comparisons of the one-way ANOVA test. Overall, no
group difference was found in the GZ and hilus regions across all groups in both ipsilateral and
50

contralateral side of injury (Figure 3.6). This data suggests that Notch transient signaling
manipulation does not have prolonged effect on hippocampal neurogenesis.
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Figure 3.5 Visualization of DCX+ cells in the GZ and Hilus regions. DCX immunostaining was
carried out in (A) Sham, (B)FPI+Vehicle, (C) FPI+Jagged-1 Fc, and (D) FPI+Notch1 groups. Scale
bar = 100 µm. Different dendritic morphology was shown: (E) vertical, (F) mixed, or (G)
horizontal. The arrows identify corresponding examples of positively stained DCX cells. Scale
bar = 20 µm.
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Figure 3.6 Quantification of DCX positive cells at 30 Days Post-Injury. Stereological counts
were completed to determine the number of DCX+ cells across all four treatment groups.
Counts were completed across the ipsilateral and contralateral (A) GZ and (B) Hilus for all
animals. No significant differences were found in the multi-group comparisons. Error bars set to
2x SE.
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Chapter 4 – Discussion
Traumatic brain injury stands as a global health issue affecting millions of people each
year. In the United States alone, TBI is estimated to have affected over a million people from
1995 through 2001 according to the CDC. 69 Of that group, 50,000 individuals died from the
event, while 1.1 million were treated and released. As technology continues to improve, a
greater number of people will survive TBI-related incidents, therefore creating greater risk of
post-TBI complications over time. It is our hope that increasing the understanding of how TBI
affects the brain will allow for immediate, efficient treatment to limit, or perhaps even prevent,
the outstanding secondary injuries commonly associated with this injury model.
In this dissertation, we have discussed a very brief overview of the study of
neurogenesis, the Notch signaling pathway, TBI, and how all three of those are intertwined.
Neurogenesis is a crucial process during homeostatic and pathological conditions. Notch
signaling, one of the key mechanisms in regulating neurogenesis, plays a vital role in normal
development of the brain 70 and maintenance in later stages of adulthood.48 Specifically, the
Notch1 signaling pathway plays a role in proliferation, differentiation, and apoptosis of NSCs in
direct association with specific cellular signals. Our lab has explored the role of Notch signaling
in regulating the regenerative neural stem cell response following TBI. 20,44,71 Thus far, we have
analyzed the short-term effects of Notch manipulation; this study questioned the long-term
effects of Notch manipulation in the neurogenic niches of the brain during the chronic stage
following TBI to gain insight on how post-injury regenerative stem cells are affected by Notch
signaling.
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Summary of Results
In this study, we analyzed the significance of the Notch signaling pathway manipulation
in adult neurogenesis following TBI. Notch pathway manipulation was achieved by
intraventricular infusion of Notch1 inhibitor Jagged-1 Fc or Notch1 activator Notch1 antibody
for 7 days immediately following a lateral fluid percussive injury. Animals were sacrificed at 30
days post-injury. The number of BrdU-positive cells that were labeled via intraperitoneal BrdU
injection during the infusion period was utilized as the indicator of Notch manipulation on
neural stem cell proliferation and survival, whereas immature neuronal marker DCX was used
as the indicator of generation of new neurons. We found that at 30 days post-injury, the
FPI+Notch1 agonist group had a significant increase in survival of proliferated cells, as
measured with BrdU+ cell quantification, when compared to Sham groups in both the granular
zone (GZ) and hilus region of the dentate gyrus (DG) in the hippocampus. The FPI+Notch1 group
also had significantly higher number of BrdU+ cells compared to FPI+Jagged-1 Fc group on both
the ipsilateral and contralateral Hilus, as well as the contralateral GZ. In addition, there was a
significant increase in proliferation in FPI+Vehicle versus Sham groups throughout the Hilus.
In the assessment of DCX+ cells, we found that no significant differences were
established when comparing Sham, FPI+Vehicle, FPI+Jagged-1 Fc, and FPI+Notch1 groups.
Within the ipsilateral GZ, Sham and FPI+Vehicle maintained roughly the same mean values of
DCX+ cells, although both FPI+Jagged-1 Fc and FPI+Notch1 had a tendency for a slightly lower
mean value in this region. On the contralateral side of injury, elevated levels of DCX+ cells were
seen in the FPI+Vehicle group when compared against other groups in the GZ of the
hippocampus. FPI+Notch1 maintained a lower value of doublecortin-positive cells throughout
56

the GZ. In the hilus, DCX+ cells were highest in the FPI+Vehicle group on both the ipsilateral and
contralateral side of injury. There was a tendency for a slight increase in DCX-positive cells for
both the FPI+Notch1 and FPI+Jagged-1 Fc groups when compared to sham in the ipsilateral
hilus as well, but no corresponding trend on the contralateral side of injury.

Cellular Proliferation at 30 DPI
In a previous experiment carried out in our lab, cellular proliferation following TBI was
analyzed at 7 DPI in the GZ and hilus regions of the hippocampus. Comparatively, in the current
study we set out to determine the longer-term effects of Notch signaling following TBI at 30
DPI. This experiment helped further the understanding what happens in the DG following
traumatic brain injury and what effect manipulation of the Notch signaling pathway has on
cellular proliferation at 30 DPI.
Pharmacological manipulation to upregulate the Notch1 signaling pathway was directly
responsible for increased cell proliferation in the hippocampus. In the current study, a
significant increase in the number of BrdU+ cells was observed in the GZ and the hilus region of
the contralateral side of injury, and close to significant increase in the GZ of the ipsilateral side
of GZ (p=0.057) in animals that received Notch1 activator treatment compared to Sham and
injured animals with Notch1 inhibitor treatment. Additionally, the FPI+Vehicle group had a
significant increase of positive BrdU cells when compared to Sham animals. These data suggest
that injury alone was enough to cause a significant increase in cellular proliferation/survival in
the DG of animals, which is in agreement with our previous observation. 72 Our data also suggest
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that activation of the Notch1 pathway on top of injury does not provide further enhancement
of cell proliferation/survival as no difference was observed between injured vehicle group and
Notch1 activator group. Our previous study found that TBI can enhance Notch pathway
activation by upregulation of the Notch1 pathway protein expression levels during the acute
post-injury stage. At this timepoint, Notch ligand and receptor binding may have already
reached maximal efficiency, thus supplementation with exogenous Notch1 activator does not
have any additional effect. However, in this study, inhibition of the Notch pathway using
Jagged-1 Fc prevented the proliferative response, suggesting that Notch signaling is uniquely
involved in the endogenous proliferative response.

Neural Generation at 30 DPI
Identification of doublecortin-positive cells has served as an important tool for
observing adult neurogenesis in mammals. 73 DCX is a known microtubule associated protein
that stabilizes the cellular skeleton of immature and migrating neurons. 65 In analyzing neural
differentiation of our tissue, we ran the sections through a series of immunological steps using
an antibody against DCX to mark newly generated neurons.
In this experiment, we observed slightly higher number of DCX-positive cells in
FPI+Vehicle when compared to Sham animals. Interestingly, we saw a relative decrease in DCXpositive cells in both the FPI+Notch1 and FPI+Jagged-1 groups. In part, these finding remain
consistent with what we anticipated to be true; for our FPI+Notch1 agonist group, higher levels
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of proliferation were expected to result in a relative inhibition of levels of differentiation. We
observed this trend throughout the granular zone and in portions of the hilus.
This trend corresponds with what we know about Notch activation and what previous
studies have demonstrated as well. Upregulation of the Notch pathway should result in
increased negative transcription regulators like Hes genes, which are known to antagonize proneural genes, thus preventing differentiation.46 Other studies demonstrated that inhibition of
the Notch pathway in stem cells, both in vivo and in vitro, resulted in accelerated neural
differentiation.74 DCX is a widely used marker for detecting of newly generated neurons during
the 2-week period following generation. As the Notch1 activator and inhibitor were
administrated only for the first 7 days post-injury, whereas the animals were sacrificed at 30
days post-injury, DCX+ cells that we observed were new neurons generated around 15-30 days
post-injury, well after the termination of Notch1 manipulation. Our data suggested that shortterm modulation of Notch1 signaling with pharmacological agents does not have prolonged
effect on neurogenesis. Our data showed the trend of a lower number of DCX+ cells in the GZ
and hilus region in animals that received Notch manipulation compared to Sham and injuryVehicle groups. That the statistical difference is not significant is possibly due to the big
variable. Increasing animal number for each group may reduce the variable and provide more
accurate information.
Our data allows us to further understand how TBI affects the neurogenic regions of the
brain. Upregulation of the Notch1 signaling pathway resulted in an overall increase in survival
of proliferated cells in response to injury when compared to Sham animals; however, what is
not yet understood is the outcome of these proliferated cells. Further studies using double59

labeling techniques, examining the fate of differentiation of the BrdU-labeled cells with
different cell markers, such as mature neuronal marker, astrocytes, and other glial cell markers
as well as neural stem cell markers will answer this question.

Conclusion and Future Direction
Much has been done to understand, prevent, and treat TBI over the last few decades,
but much work remains. In this study, we have analyzed a portion of the long-term role that the
Notch signaling pathway plays in regulating endogenous neurogenesis in the adult brain
following TBI. We found that upregulation of Notch signaling, through intraventricular infusion
of Notch1 antibody, causes a significant increase in cell proliferation/survival at 30 DPI in the
DG of the hippocampus. While significant cellular proliferation was observed in the DG,
upregulation of the Notch pathway at the acute stage post-injury does not have prolonged
effect in generation of new neurons during the chronic stage following injury. As the current
study lacks examination of the fate mapping of Notch1 activation-induced proliferated cells,
also taking into consideration the relative low number of animals included in this study, the
results of the current study are not conclusive. In order to solidify our understanding of what
occurred, increasing animal numbers across groups could allow for greater clarity. Additionally,
further experimentation using double-labeling to determine quantity of mature neurons (using
NeuN) or astrocyte proliferation (with GFAP) could help expose wherein lies the difference in
cell type.
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